<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Hypertonic salt solution for peri‐operative fluid management - Shrum, B - 2016 | Cochrane Library</title> <meta content="Hypertonic salt solution for peri‐operative fluid management - Shrum, B - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005576.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Hypertonic salt solution for peri‐operative fluid management - Shrum, B - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005576.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005576.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Hypertonic salt solution for peri‐operative fluid management" name="citation_title"/> <meta content="Brad Shrum" name="citation_author"/> <meta content="University Hospital London Health Sciences Centre" name="citation_author_institution"/> <meta content="Brian Church" name="citation_author"/> <meta content="Department of Anesthesia, University of Western Ontario" name="citation_author_institution"/> <meta content="Eric McArthur" name="citation_author"/> <meta content="Victoria Hospital" name="citation_author_institution"/> <meta content="Karen EA Burns" name="citation_author"/> <meta content="Keenan Research Centre/Li Ka Shing Knowledge Institute, University of Toronto" name="citation_author_institution"/> <meta content="Tammy Znajda" name="citation_author"/> <meta content="Lakeshore General Hospital" name="citation_author_institution"/> <meta content="Vivian McAlister" name="citation_author"/> <meta content="University of Western Ontario" name="citation_author_institution"/> <meta content="vmcalist@uwo.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD005576.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/06/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005576.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005576.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005576.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Surgical Procedures, Operative; Crystalloid Solutions; Fluid Therapy [*adverse effects, *methods]; Isotonic Solutions [administration &amp; dosage, adverse effects]; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic [*administration &amp; dosage, adverse effects]; Sodium [blood]; Water‐Electrolyte Balance" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005576.pub3&amp;doi=10.1002/14651858.CD005576.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="4nUWI3Cc";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005576\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005576\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","hr","pl","fr","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005576.pub3",title:"Hypertonic salt solution for peri\\u2010operative fluid management",firstPublishedDate:"Jun 6, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=4nUWI3Cc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005576.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005576.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005576.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005576.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005576.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005576.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005576.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005576.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005576.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005576.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4114 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005576.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0114"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0085"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-sec-0108"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/appendices#CD005576-sec-0119"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/table_n/CD005576StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/table_n/CD005576StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Hypertonic salt solution for peri‐operative fluid management</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0002">Brad Shrum</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0003">Brian Church</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0004">Eric McArthur</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0005">Karen EA Burns</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0006">Tammy Znajda</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information#CD005576-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Vivian McAlister</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information/en#CD005576-sec-0128">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 June 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005576.pub3">https://doi.org/10.1002/14651858.CD005576.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005576-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005576-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005576-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005576-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005576-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005576-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005576-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005576-abs-0001" lang="en"> <section id="CD005576-sec-0001"> <h3 class="title" id="CD005576-sec-0001">Background</h3> <p>Fluid excess may place people undergoing surgery at risk for various complications. Hypertonic salt solution (HS) maintains intravascular volume with less intravenous fluid than isotonic salt (IS) solutions, but may increase serum sodium. This review was published in 2010 and updated in 2016. </p> </section> <section id="CD005576-sec-0002"> <h3 class="title" id="CD005576-sec-0002">Objectives</h3> <p>To determine the benefits and harms of HS versus IS solutions administered for fluid resuscitation to people undergoing surgery. </p> </section> <section id="CD005576-sec-0003"> <h3 class="title" id="CD005576-sec-0003">Search methods</h3> <p>In this updated review we have searched the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 4, 2016); MEDLINE (January 1966 to April 2016); EMBASE (January 1980 to April 2016); LILACS (January 1982 to April 2016) and CINAHL (January 1982 to April 2016) without language restrictions. We conducted the original search on April 30th, 2007, and reran it on April 8th, 2016. </p> </section> <section id="CD005576-sec-0004"> <h3 class="title" id="CD005576-sec-0004">Selection criteria</h3> <p>We have included randomized clinical trials (RCTs) comparing HS to IS in people undergoing surgery, irrespective of blinding, language, and publication status. </p> </section> <section id="CD005576-sec-0005"> <h3 class="title" id="CD005576-sec-0005">Data collection and analysis</h3> <p>Two independent review authors read studies that met our selection criteria. We collected study information and data using a data collection sheet with predefined parameters. We have assessed the impact of HS administration on mortality, organ failure, fluid balance, serum sodium, serum osmolarity, diuresis and physiologic measures of cardiovascular function. We have pooled the data using the mean difference (MD) for continuous outcomes. We evaluated heterogeneity between studies by I² percentage. We consider studies with an I² of 0% to 30% to have no or little heterogeneity, 30% to 60% as having moderate heterogeneity, and more than 60% as having high heterogeneity. In studies with low heterogeneity we have used a fixed‐effect model, and a random‐effects model for studies with moderate to high heterogeneity. </p> </section> <section id="CD005576-sec-0006"> <h3 class="title" id="CD005576-sec-0006">Main results</h3> <p>We have included 18 studies with 1087 participants of whom 545 received HS compared to 542 who received IS. All participants were over 18 years of age and all trials excluded high‐risk patients (ASA IV). All trials assessed haematological parameters peri‐operatively and up to three days post‐operatively. </p> <p>There were three (&lt; 1%) deaths reported in the IS group and four (&lt; 1%) in the HS group, as assessed at 90 days in one study. There were no reports of serious adverse events. Most participants were in a positive fluid balance postoperatively (4.4 L IS and 2.5 L HS), with the excess significantly less in HS participants (MD ‐1.92 L, 95% confidence interval (CI) ‐2.61 to ‐1.22 L; P &lt; 0.00001). IS participants received a mean volume of 2.4 L and HS participants received 1.49 L, significantly less fluid than IS‐treated participants (MD ‐0.91 L, 95% CI ‐1.24 to ‐0.59 L; P &lt; 0.00001). The maximum average serum sodium ranged between 138.5 and 159 in HS groups compared to between 136 and 143 meq/L in the IS groups. The maximum serum sodium was significantly higher in HS participants (MD 7.73, 95% CI 5.84 to 9.62; P &lt; 0.00001), although the level remained within normal limits (136 to 146 meq/L). </p> <p>A high degree of heterogeneity appeared to be related to considerable differences in the dose of HS between studies. The quality of the evidence for the outcomes reported ranged from high to very low. The risk of bias for many of the studies could not be determined for performance and detection bias, criteria that we assess as likely to impact the study outcomes. </p> </section> <section id="CD005576-sec-0007"> <h3 class="title" id="CD005576-sec-0007">Authors' conclusions</h3> <p>HS reduces the volume of intravenous fluid required to maintain people undergoing surgery but transiently increases serum sodium. It is not known if HS affects survival and morbidity, but this should be examined in randomized controlled trials that are designed and powered to test these outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005576-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005576-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005576-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005576-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005576-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005576-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005576-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005576-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD005576-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005576-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005576-abs-0016">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005576-abs-0004" lang="en"> <h3>Increased salt in solution to maintain fluid during surgery</h3> <p><b>Review question</b> </p> <p>Are solutions containing more salt than is normally used safe during surgery?</p> <p><b>Background</b> </p> <p>People usually require fluids during surgery. Sometimes large volumes of fluid are given in order to maintain adequate blood volume, but these volumes may leave people with too much fluid. The fluids normally used during surgery have a salt balance similar to that found in blood, and are called isotonic. Hypertonic salt solutions (HS) have a higher sodium concentration than isotonic salt solutions (IS). HS might benefit people undergoing surgery by reducing the total volume of fluid required. </p> <p><b>Search date</b> </p> <p>The evidence is up to date to April 8th, 2016.</p> <p><b>Study characteristics</b> </p> <p>We included 18 trials that compared HS to IS in people undergoing surgery. The trials included 1087 participants. Five hundred and forty‐five (545) participants received HS and 542 received IS during their operations. The participants were randomly assigned to their groups. The studies took place in 11 countries. Study participants were over the age of 18. All studies excluded people with serious health risks from participating. All studies monitored fluid levels during the operation and up to three days after. </p> <p><b>Key results</b> </p> <p>There were seven deaths in total, three (less than 1%) from the IS group and four (less than 1%) from the HS group. The risk of death was very low in these studies. The studies did not report the occurrence of serious adverse events. </p> <p>Thirteen studies reported the amount of fluid given. The IS group received a mean of 2.4 L and the HS group received 0.91 L less (1.49 L). The highest amount of sodium in the blood over the course of the study was reported by 16 studies. The IS group had a median of 139 meq/L and the HS group was 7.73 meq/L higher. The normal acceptable range is 136 to 146 meq/L. </p> <p><b>Quality of the evidence</b> </p> <p>For deaths and adverse events the trials lacked sufficient size and duration to adequately assess differences. We assessed the quality of evidence for deaths to be very low, and future studies are likely to change the result reported here. </p> <p>The reporting of the highest amount of sodium is of moderate quality. The measuring of blood sodium during an operation is a common measurement that is unlikely to be misrepresented. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005576-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005576-sec-0114"></div> <h3 class="title" id="CD005576-sec-0115">Implications for practice</h3> <section id="CD005576-sec-0115"> <p>There was insufficient evidence from the included studies to suggest that the use of HS confers any clinical benefit or harm in terms of mortality or major morbidity compared to the use of IS. There is no reason to prefer HS for the routine management of people having surgery. The reduction in positive fluid balance when using HS may suggest HS would be an appropriate choice when fluid restriction is required in selected individuals or clinical situations. </p> </section> <h3 class="title" id="CD005576-sec-0116">Implications for research</h3> <section id="CD005576-sec-0116"> <p>HS administration to people undergoing surgery should be compared to standard practice, using RCTs of high methodological rigour in order to determine any impact on participant survival and other clinically relevant outcomes. Sample size estimation is problematic, given the very low reported incidence of mortality or significant morbidity in the control groups in these trials. The duration of any future trial should be sufficient to cover the period of peri‐operative mortality or major morbidity which is usually considered to be 60 days or at least the postoperative hospital stay. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005576-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005576-sec-0036"></div> <div class="table" id="CD005576-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> any people undergoing surgery with fluid resuscitation<br/> <b>Settings:</b> people undergoing non‐emergency surgery that requires fluid resuscitation in a hospital operating room in;Brazil, China,Denmark, Finland, France, Germany, Indonesia, Japan, Lebanon, Niger, USA.<br/> <b>Intervention:</b> hypertonic salt solution<br/> <b>Comparison:</b> isotonic salt solution </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> isotonic salt solution for peri‐operativeresuscitation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Hypertonic salt</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality</p> <p>Follow‐up: range 1 to 90 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1087<br/> (18 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Any recorded death during the study period. The risk of bias impacting this outcome is considered to be low. Only one study had incidents of mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> <p>Follow‐up: range 1 to 90 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1087</p> <p>(18 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse outcomes are collected as defined by each trial or if any of the following occurred: any organ failure, including renal, pulmonary, cardiac, or cerebral </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluid balance (L)</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fluid balance (L) was 4.375</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fluid balance (L) in the intervention group was 1.92 lower (2.61 lower to 1.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>737<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The change in participant fluid volume at the end of fluid administration. A neutral fluid balance would be optimal </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total volume of crystalloid administered (L)</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of crystalloid administered (L) was 2.43</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of crystalloid administered (L) in the intervention group was 0.91 lower (1.24 lower to 0.59 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>871<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total volume of fluid delivered intravenously over the study period. There are no defined minimum or maximum values for fluid delivery during surgery. Less resuscitating fluid is preferred </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peak serum sodium</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean peak serum sodium (meq/L) was 139.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean peak serum sodium (meq/L) in the intervention group was 7.73 higher (5.84 higher to 9.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>780<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is a common practice in operative procedures. Measured as the peak amount of sodium in the blood, given in milliequivelants per litre, over the study period. The normal acceptable range is 136 to 146 meq/L </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final serum sodium</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final serum sodium (meq/L) was 138.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final serum sodium (meq/L) in the intervention group was 3.45 higher (2.46 higher to 4.44 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is common practice in operative procedures. Measured as the final amount of sodium in the blood, given in milliequivelants per litre, at the end of the study. The normal acceptable range is 136 to 146 meq/L </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum intraoperative cardiac index</p> <p>Follow‐up: 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maximum intraoperative cardiac index (L/min/M²) was 2.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maximum intraoperative cardiac index (L/min/m²) in the intervention group was 0.34 higher (0.19 higher to 0.49 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is common practice in operative procedures. Measured by the volume of blood passing through one square meter each minute (L/min/M²). The normal range is 2.5 ‐ 4.0 L/min/M² </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded (2 levels) for indirectness: The majority of studies have an insufficient follow‐up period to adequately measure the outcome.<br/> <sup>2</sup>Downgraded (1 level) for publication bias: Only one study contributes explicit evidence for the outcome.<br/> <sup>3</sup>Downgraded (1 level) for risk of bias: The majority of the studies have not confirmed blinding of outcome assessors; bias could seriously impact this result.<br/> <sup>4</sup>Downgraded (1 level) for imprecision: The volume of crystalloid solution delivered between studies has a large range.<br/> <sup>5</sup>Downgraded (1 level) for imprecision: The duration of sample collection varies widely from study to study. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005576-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005576-sec-0037"></div> <section id="CD005576-sec-0038"> <h3 class="title" id="CD005576-sec-0038">Description of the condition</h3> <p>Low‐volume resuscitation with hypertonic crystalloid solutions has been investigated for over 20 years (<a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>). More recently, alterations in cellular immune function with hypertonic salt solution (HS) administration have been demonstrated in experimental and clinical studies (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0039" title="RizoliSB , RhindSG , ShekPN , InabaK , FilipsD , TienH , et al. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double‐blinded trial. Annals of Surgery2006;243(1):47‐57. [MEDLINE: 16371736] ">Rizoli 2006</a>). Several randomized controlled trials (RCTs) of HS resuscitation in critically ill participants have been performed. A systematic review of HS compared to isotonic salt solution (IS) in resuscitation following burns or trauma was unable to reach a conclusion regarding benefit or harm in the presence of wide confidence intervals (<a href="./references#CD005576-bbs2-0028" title="BunnF , RobertsI , TaskerR , AkpaE . Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD002045.pub2; MEDLINE: 15266460] ">Bunn 2004</a>). Trials of HS alone, or in combination with colloids, have also been performed in the trauma population. A meta‐analysis comparing 250 mL of HS (with or without dextran) with administration of 250 mL of isotonic crystalloid for the treatment of hypotension either in the field or at admission to the emergency department in 1233 trauma patients failed to demonstrate that HS with dextran confers a survival benefit (<a href="./references#CD005576-bbs2-0042" title="WadeCE , KramerGC , GradyJJ , FabianTC , YounesRN . Efficacy of hypertonic 7.5% saline and 6% dextran‐70 in treating trauma: a meta‐analysis of controlled clinical studies. Surgery1997;122(3):609‐16. [MEDLINE: 9308620] ">Wade 1997</a>). </p> </section> <section id="CD005576-sec-0039"> <h3 class="title" id="CD005576-sec-0039">Description of the intervention</h3> <p>Standard peri‐operative care includes IS administration to counter conditions which may cause transient intraoperative hypovolaemia including: fluid deprivation during preoperative fasting; vasodilatation due to epidural or general anaesthesia; third space sequestration of intravascular fluid; insensible fluid loss and intraoperative fluid or blood loss. These conditions are often reversed at the end of an operation. In fact, IS has been shown to increase the weight of people undergoing elective major surgery by an average of three to six kilograms (kg) (<a href="./references#CD005576-bbs2-0032" title="GrocottMP , MythenMG , GanTJ . Perioperative fluid management and clinical outcomes in adults. Anesthesia and Analgesia2005;100(4):1093‐106. [MEDLINE: 15781528] ">Grocott 2005</a>). While most people tolerate the additional fluid well, postoperative improvement or reversal of the conditions outlined above may place those with compromised cardiovascular or renal function at increased risk for development of pulmonary oedema. People without cardiovascular or renal risk factors may also be adversely affected by peri‐operative fluid gain. A recent RCT demonstrated that peri‐operative fluid restriction resulted in fewer major or minor postoperative complications compared to traditional care in 172 adult participants undergoing elective colorectal surgery (<a href="./references#CD005576-bbs2-0027" title="BrandstrupB , TonnesenH , Beier‐HolgersenR , HjortsoE , OrdingH , Lindorff‐LarsenK , et al: Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor‐blinded multicenter trial. Annals of Surgery2003;238(5):641‐8. [MEDLINE: 14578723] ">Brandstrup 2003</a>). Another study demonstrated that fluid overload delayed return of gastrointestinal function (<a href="./references#CD005576-bbs2-0035" title="LoboDN , BostockKA , NealKR , PerkinsAC , RowlandsBJ , AllisonSP . Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet2002;359(9320):1812‐8. [MEDLINE: 12044376] ">Lobo 2002</a>). Conversely, failure to maintain intravascular volume during surgery may place people at risk for cardiac or cerebral ischaemia. Indeed, supplemental peri‐operative fluid administration has been shown to improve tissue oxygenation (<a href="./references#CD005576-bbs2-0026" title="ArkiliçCF , TaguchiA , SharmaN , RatnarajJ , SesslerDI , ReadTE , et al. Supplemental perioperative fluid administration increases tissue oxygen pressure. Surgery2003;133(1):49‐55. [MEDLINE: 12563237] ">Arkiliç 2003</a>). </p> </section> <section id="CD005576-sec-0040"> <h3 class="title" id="CD005576-sec-0040">How the intervention might work</h3> <p>HS has the potential to reduce the total volume of fluid administered during operative procedures by allowing people to draw fluid from the interstitium (and other body compartments) to counter peri‐operative hypotensive effects, and thereby provide Intravascular support without excess fluid administration. In situations where large volume resuscitation may be harmful, such as in brain trauma, a role for HS is emerging (<a href="./references#CD005576-bbs2-0037" title="OgdenAT , MayerSA , ConnollyESJr . Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery2005;57(2):207‐15. [MEDLINE: 16094147] ">Ogden 2005</a>). Notwithstanding, several risks have been associated with HS, including potential hypernatraemia, metabolic acidosis and vasodilatation. </p> </section> <section id="CD005576-sec-0041"> <h3 class="title" id="CD005576-sec-0041">Why it is important to do this review</h3> <p>Several RCTs of prophylactic HS administration in the peri‐operative period have been published. In contrast to other trials where HS has been combined with colloid solutions to treat hypotension, these RCTs may provide a clinical picture of the effect of HS on peri‐operative fluid management. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005576-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005576-sec-0042"></div> <p>To determine the benefits and harms of HS versus IS solutions administered for fluid resuscitation to people undergoing surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005576-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005576-sec-0043"></div> <section id="CD005576-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005576-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included RCTs comparing the administration of HS versus IS solution during non‐emergency operative procedures, regardless of language or publication status. RCTs are the gold standard for comparing the effect of one treatment versus another. </p> </section> <section id="CD005576-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included all participants undergoing any surgical procedures.</p> </section> <section id="CD005576-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We have included peri‐operative administration of either HS or IS solutions. We permitted concomitant measures so long as they applied to both arms of the study. We excluded studies that compared HS and a colloidal solution to IS alone. Additionally, we excluded studies that compared HS and IS solutions administered by inhalation or absorption from the nasal mucosa and involving non‐surgical patient populations (burns, trauma and head injury). </p> </section> <section id="CD005576-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD005576-sec-0049"> <h5 class="title">Primary outcomes</h5> <section id="CD005576-sec-0050"> <h6 class="title">1. Mortality</h6> <p>Defined as any deaths occurring during the study period. Where all participants are included in the results for other outcomes we have extrapolated that as indicating no deaths. </p> </section> <section id="CD005576-sec-0051"> <h6 class="title">2. Serious adverse events</h6> <p>We collected other adverse outcomes as defined by each trial, or if any of the following occurred: any organ failure, any requirement for dialysis (renal failure) or prolonged ventilation (pulmonary failure); use of medical therapy for either pulmonary oedema or circulatory support (cardiac failure) or for confusion (cerebral failure). </p> </section> </section> <section id="CD005576-sec-0052"> <h5 class="title">Secondary outcomes</h5> <section id="CD005576-sec-0053"> <h6 class="title">3. Fluid balance over the study period</h6> <p>We used authors' definitions where provided. For studies not clearly specifying the study period, we defined it to include the immediate preoperative (induction of anaesthesia), intraoperative and postoperative periods (up to 24 hours after surgery). Studies can report the fluid balance by reporting the difference in fluid given minus fluid excreted or by the change in weight of the participant. For studies that only reported weight change, we applied a conversion factor, wherein 1 kg = 1 L (litre), to calculate fluid balance. Fluid balance is expressed in litres. </p> </section> <section id="CD005576-sec-0054"> <h6 class="title">4. Total volume of intravenous fluid delivered</h6> <p>A report of the volume of resuscitating fluid given to the participant intravenously during the peri‐operative and recovery period as reported by the studies. Fluid delivered is expressed in litres. </p> </section> <section id="CD005576-sec-0055"> <h6 class="title">5. Peri‐operative diuresis</h6> <p>A measure of the urine output from the participant during the operative period. Diuresis is reported as litres. </p> </section> <section id="CD005576-sec-0056"> <h6 class="title">6. Maximum serum sodium concentration</h6> <p>As measured from the participant's blood during the study and reported as milliequivalents per litre (meq/L). </p> </section> <section id="CD005576-sec-0057"> <h6 class="title">7. Final serum sodium concentration</h6> <p>As measured in the participant's blood at the end of follow‐up, and reported as milliequivalents per litre (meq/L). </p> </section> <section id="CD005576-sec-0058"> <h6 class="title">8. Duration of endotracheal intubation after operation</h6> <p>As reported by each study and converted to hours (h).</p> </section> <section id="CD005576-sec-0059"> <h6 class="title">9. Duration of stay in intensive care after operation</h6> <p>As reported by each study and converted to hours (h).</p> </section> <section id="CD005576-sec-0060"> <h6 class="title">10. Duration of stay in hospital after operation</h6> <p>As reported by each study and converted to days (d).</p> </section> <section id="CD005576-sec-0061"> <h6 class="title">11. Other outcomes</h6> <p>We collected data regarding serum osmolarity, expressed as milliosmoles per kilogram of water (mOsm/kg H2O) and peri‐operative haemodynamic parameters: pulmonary artery wedge pressure, measured by mm of mercury (mm Hg); and cardiac index (CI), derived from cardiac output (CO = Heart rate/stroke volume/1000) and body surface area (BSA), CI = CO/BSA; it is a measure of the volume of blood passing through one square meter each minute (L/min/M²). </p> </section> </section> </section> </section> <section id="CD005576-sec-0062"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005576-sec-0063"> <h4 class="title">Electronic searches</h4> <p>For this updated review we have searched the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 4, 2016); MEDLINE (January 1966 to April 2016); EMBASE (January 1980 to April 2016); LILACS (January 1982 to April 2016) and CINAHL (January 1982 to April 2016). We limited the publication types to clinical trials, controlled clinical trials, RCTs, multicentre studies and meta‐analyses, without language restrictions. </p> <p>We originally used the search strategy described in the appendices (<a href="./appendices#CD005576-sec-0120">Appendix 1</a> MEDLINE; <a href="./appendices#CD005576-sec-0121">Appendix 2</a> EMBASE; <a href="./appendices#CD005576-sec-0122">Appendix 3</a> CINAHL; <a href="./appendices#CD005576-sec-0123">Appendix 4</a> LILACS; <a href="./appendices#CD005576-sec-0124">Appendix 5</a> CENTRAL) to search until August 2009. We have updated the search terms since the original search (see <a href="./appendices#CD005576-sec-0125">Appendix 6</a>). In addition, we searched trial registries including <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>, <a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com/</a> and <a href="http://www.ifpma.org/clinicaltrials.html" target="_blank">www.ifpma.org/clinicaltrials.html</a> for ongoing trials. We sought letter or email contact with principal investigators to inform them of the meta‐analysis and to ask for additional information. </p> <p>The search was last run on April 8th, 2016.</p> </section> <section id="CD005576-sec-0064"> <h4 class="title">Searching other resources</h4> <p>We handsearched the bibliographies of retrieved articles and the abstracts of conference proceedings published in <i>Anaesthesia and Intensive Care</i> ; <i>Anaesthesia and Analgesia; British Journal of Surgery; Critical Care Medicine</i> ; <i>Journal of Vascular Surgery and Trauma; Injury;</i> and<i>Infection and Critical Care</i> for the years 2000 to 2006. </p> </section> </section> <section id="CD005576-sec-0065"> <h3 class="title" id="CD005576-sec-0065">Data collection and analysis</h3> <section id="CD005576-sec-0066"> <h4 class="title">Selection of studies</h4> <p>Vivian McAlister (VM) with Brad Shrum (BS) scanned titles and abstracts identified by the initial search to exclude overlapped and irrelevant studies. Three authors (Tammy Znajda (TZ), Karen Burns (KB) and BS) identified trials that met our inclusion criteria. Brian Church (BC) resolved differences in data recorded and we resolved all differences of opinion through discussion. </p> </section> <section id="CD005576-sec-0067"> <h4 class="title">Data extraction and management</h4> <p>At least two of the review authors abstracted data independently from the studies, using standardized forms developed for this review. We wrote to primary study authors for information regarding missing data or data that were not clearly stated. We resolved differences of opinion through discussion. We abstracted data pertaining to the included participants, interventions applied and outcomes reported for each trial. Where translation was needed we sought the help of native speakers of the language who had scientific training. The translator collected relevant information on the data collection forms provided. </p> <p>We abstracted the following details from each of the included studies:</p> <p> <ol id="CD005576-list-0001"> <li> <p>Participants (inclusion and exclusion criteria; mean age; proportion of men; aetiology of disease; weight before and after surgery; serum electrolytes before, during and after surgery); </p> </li> <li> <p>Interventions (type of surgery; concentration and volume of hypertonic saline given; total volume of fluid administered and concomitant therapy); </p> </li> <li> <p>Trials (setting; methodological quality; publication status; duration of follow‐up and all outcomes). </p> </li> </ol> </p> </section> <section id="CD005576-sec-0068"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We based our assessment of 'Risk of bias' on the recommendations provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005576-bbs2-0033" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The assessments were based on the allocation sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting, and other potential biases (<a href="./references#CD005576-bbs2-0036" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>; <a href="./references#CD005576-bbs2-0043" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.)2008;336(7644):601‐5. ">Wood 2008</a>). </p> <section id="CD005576-sec-0069"> <h5 class="title">Allocation sequence generation</h5> <p>Low risk of bias: sequence generation was achieved using computer random‐number generation or a random‐number table. Drawing lots, tossing a coin, shuffling cards, and throwing dice were adequate if performed by an independent person not otherwise involved in the trial. </p> <p>Uncertain risk of bias: the method of sequence generation was not specified.</p> <p>High risk of bias: the sequence generation method was not random.</p> </section> <section id="CD005576-sec-0070"> <h5 class="title">Allocation concealment</h5> <p>Low risk of bias: the participant allocations could not have been foreseen in advance of, or during, enrolment. Allocation was controlled by a central and independent randomization unit. The allocation sequence was unknown to the investigators (for example, if the allocation sequence was hidden in sequentially‐numbered, opaque, and sealed envelopes). </p> <p>Uncertain risk of bias: the method used to conceal the allocation was not described so that intervention allocations may have been foreseen in advance of, or during, enrolment. </p> <p>High risk of bias: the allocation sequence was likely to be known to the investigators who assigned the participants. </p> </section> <section id="CD005576-sec-0071"> <h5 class="title">Blinding of participants, personnel, and outcome assessors</h5> <p>Low risk of bias: blinding was performed adequately. Additionally, we defined lack of blinding (detection and performance bias) as not likely to affect the assessment of the outcome mortality. </p> <p>Uncertain risk of bias: there was insufficient information to assess whether blinding was likely to introduce bias in the results. </p> <p>High risk of bias: no blinding or incomplete blinding, and the assessment of outcomes were likely to be influenced by lack of blinding (all other outcomes than mortality and non‐subjective laboratory measures). </p> </section> <section id="CD005576-sec-0072"> <h5 class="title">Incomplete outcome data</h5> <p>Low risk of bias: missing data were unlikely to make treatment effects depart from plausible values. Sufficient methods, such as multiple imputation, were employed to handle missing data. </p> <p>Uncertain risk of bias: there was insufficient information to assess whether missing data in combination with the method used to handle missing data were likely to introduce bias in the results </p> <p>High risk of bias: the results were likely to be biased due to missing data.</p> </section> <section id="CD005576-sec-0073"> <h5 class="title">Selective outcome reporting</h5> <p>Low risk of bias: the trial reported clinically relevant outcomes, which we defined as mortality, hepatic encephalopathy, and serious adverse events. If we had access to the original trial protocol, the outcomes should be those specified in that protocol. If we obtained the protocol from a trial registry such as <a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>, we only used the information if the investigators registered the trial before inclusion of the first participant. </p> <p>Unclear risk of bias: not all predefined criteria were reported fully, or it was unclear whether data on these outcomes were recorded or not. </p> <p>High risk of bias: one or more predefined outcomes were not reported.</p> </section> <section id="CD005576-sec-0074"> <h5 class="title">Other bias</h5> <p>Low risk of bias: the trial appeared to be free of other bias domains, including: medicinal dosing problems or follow‐up (as defined below). </p> <p>Uncertain risk of bias: the trial may or may not have been free of other domains that could put it at risk of bias. </p> <p>High risk of bias: there were other factors in the trial that could put it at risk of bias, such as the administration of inappropriate treatments being given to the controls (e.g. an inappropriate dose) or follow‐up (e.g. the trial included different follow‐up schedules for participants in the allocation groups being compared). </p> </section> <section id="CD005576-sec-0075"> <h5 class="title">Evidence Quality</h5> <p>The control of bias in the included trials was part of the overall assessment of the quality of the body of evidence, which we classified as ‘High’, ‘Moderate’, ‘Low’, or ‘Very Low’. We based the assessment on the specific evidence grading system developed by the GRADE collaboration (<a href="./references#CD005576-bbs2-0031" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.)2004;328(7454):1490‐8. [MEDLINE: 15205295] ">GRADE 2004</a>). </p> </section> </section> <section id="CD005576-sec-0076"> <h4 class="title">Measures of treatment effect</h4> <p>We performed the analyses in Review Manager 5 (<a href="./references#CD005576-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used the result value and number of participants in all intervention arms to calculate the mean difference (MD) for continuous outcomes, with 95% confidence intervals (CIs). </p> </section> <section id="CD005576-sec-0077"> <h4 class="title">Unit of analysis issues</h4> <p>If the standard error of the mean was recorded in a study, we converted it to standard deviation following the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> chapter 7.7.3.2. Briefly, SD = SE x Sqrt(n). </p> </section> <section id="CD005576-sec-0078"> <h4 class="title">Dealing with missing data</h4> <p>We used the last observed response carried forward (LOCF) for participants with missing data. </p> </section> <section id="CD005576-sec-0079"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity visually through the use of funnel plots and further assessed it using the I² value. We explored sources of heterogeneity through sensitivity, subgroup, and meta‐regression analyses. The analyses included the extracted participant, intervention, and trial characteristics listed above as explanatory variables. </p> </section> <section id="CD005576-sec-0080"> <h4 class="title">Assessment of reporting biases</h4> <p>We used funnel plot asymmetry to detect reporting biases where there were more than nine studies, to avoid false detections (<a href="./references#CD005576-bbs2-0040" title="SterneJAC , EggerM , SmithGD . Investigating and dealing with publication and other biases in meta‐analysis. BMJ2001;323(7304):101‐5. ">Sterne 2001a</a>; <a href="./references#CD005576-bbs2-0041" title="SterneJAC , EggerM . Funnel plots for detecting bias in meta‐analysis: Guidelines on choice of axis. Journal of Clinical Epidemiology2001;54(10):1046‐55. ">Sterne 2001b</a>). Where funnel plots appeared to have asymmetry, we deployed the test by Matthias Egger (<a href="./references#CD005576-bbs2-0030" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>) as described by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005576-bbs2-0033" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>): linear regression of intervention effect estimate against its standard error, weighted by the inverse of the variance of the intervention effect estimate. We considered reporting biases to be evident where P &lt; 0.05. </p> </section> <section id="CD005576-sec-0081"> <h4 class="title">Data synthesis</h4> <p>We combined data in fixed‐effect meta‐analysis if the group I² was less than 30%. Where I² was 30% or greater, we used random‐effects meta‐analyses. We conducted intention‐to‐treat (ITT) analyses including all participants irrespective of compliance or follow‐up. In studies that had more than two treatment arms, we incorporated only two arms of the trial into the meta‐analysis: the arm using IS and the treatment arm evaluating HS solution. If there were two HS arms, we selected the one most different in concentration from IS for analysis. Where meta‐analysis was not possible due to a lack of events we used the Clopper‐Pearson method to estimate treatment group CIs (<a href="./references#CD005576-bbs2-0029" title="ClopperC , PearsonES . The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika1934;26(4):404‐13. ">Clopper 1934</a>). </p> <section id="CD005576-sec-0082"> <h5 class="title">Summary of findings table</h5> <p>We summarize the compiled data for this meta‐analysis in the <a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>. Each outcome is shown with its anticipated incidence per 1000 people for each treatment group. The MD is shown with 95% CIs for continuous outcomes. The overall quality of the evidence for each outcome has been determined using the Guideline Development Tool from the GRADE working group criteria and that of Cochrane (<a href="./references#CD005576-bbs2-0031" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.)2004;328(7454):1490‐8. [MEDLINE: 15205295] ">GRADE 2004</a>; <a href="./references#CD005576-bbs2-0033" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We rated the quality of the evidence as high, moderate, low, or very low, and have shown it visually and textually. Where studies have been downgraded from high quality, we have used footnotes to indicate the reason. Notes are included for each outcome to briefly describe it, and if appropriate the method of measurement. </p> </section> </section> <section id="CD005576-sec-0083"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>When appropriate after consideration of statistical and clinical heterogeneity, we performed subgroup analyses based on the following a priori criteria: </p> <p> <ol id="CD005576-list-0002"> <li> <p>Type of surgery</p> </li> <li> <p>Dose of HS: trials were stratified into three comparisons according to the dose of HS, calculated as the volume of 3% HS required to give the same amount of sodium: 7 mL/kg or less (comparison 01); 7.1 to 10 mL/kg (comparison 02); &gt; 10 mL/kg (comparison 03). We specified these dose stratifications before the review was conducted on the basis of an anticipated range of HS doses </p> </li> <li> <p>Volume of crystalloid given to the control group: trials were stratified into three comparisons according to the total volume of fluid transfusion received by IS participants: &lt; 2 L (comparison 01); 2 L to 5 L (comparison 02); &gt; 5 L (comparison 03). We specified these volume stratifications in advance of the review on the basis of an anticipated range of peri‐operative fluid administration </p> </li> </ol> </p> <p>We interpreted a lack of overlap between two CIs in the subgroup analyses as representing a statistically significant difference. </p> </section> <section id="CD005576-sec-0084"> <h4 class="title">Sensitivity analysis</h4> <p>Where the data permitted we performed a sensitivity analysis using the following <i>a priori</i> criteria<i>.</i> We removed studies that were deemed to have a moderate or higher risk of bias based on the aforementioned criteria (see <a href="#CD005576-sec-0080">Assessment of reporting biases</a>). Where potential for bias was uncertain the review authors considered the potential impact of each domain on the results. For the purposes of sensitivity analysis, unknown sequence randomization or allocation concealment did not increase the risk of bias in a study, but unknown or high risk in any other domains did increased the risk of bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005576-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005576-sec-0085"></div> <section id="CD005576-sec-0086"> <h3 class="title">Description of studies</h3> <section id="CD005576-sec-0087"> <h4 class="title">Results of the search</h4> <p>From 284 reports identified by the search strategy, 25 reports met the criteria for further assessment (<a href="#CD005576-fig-0001">Figure 1</a>). Of these 25 references, we excluded seven studies after detailed review because they were not randomized (<a href="./references#CD005576-bbs2-0019" title="AulerJOC , PereiraMHC , Gomide‐AmaralRV , StolfNG , JateneAD , Rochae Silva M . Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms. Surgery1987;101:594‐601. ">Auler 1987</a>; <a href="./references#CD005576-bbs2-0023" title="ShaoYS , ZhangYT , PengKQ , QuanZY . Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma. World Journal of Gastroenterology2005;11(11):1577‐81. [MEDLINE: 15786530] ">Shao 2005</a>), did not compare to an IS group (<a href="./references#CD005576-bbs2-0021" title="LiJ , WangB , WangS , MuF . Effects of hypertonic saline ‐ hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures. International Journal of Clinical and Experimental Medicine2014;7(8):2266‐72. ">Li 2014</a>; <a href="./references#CD005576-bbs2-0022" title="LiQ , ChenH , HaoJJ , YinNN , XuM , ZhouJX . Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double‐blinded, randomised controlled trial. BMC Anesthesiology2015;15:138. NCT02037815 . Correlation of measured and calculated serum osmolality during mannitol or hypertonic saline infusion in patients after craniotomy: a study protocol and statistical analysis plan for a randomised controlled trial. clinicaltrials.gov/ct2/show/NCT02037815. ">Li 2015</a>), or did not report our desired primary or secondary outcomes (<a href="./references#CD005576-bbs2-0020" title="AulerJOCJr , ZinWA , MartinsMA , YounesRN , NegriEM , HoelzC , et al. Respiratory system mechanics in patients treated with isotonic or hypertonic NaCl solutions. Circulatory Shock1992;36(4):243‐8. ">Auler 1992</a>; <a href="./references#CD005576-bbs2-0024" title="YangZ , ZongZ , KeC , WeiY , YuD , WangL , et al. Hetastarch with hypertonic saline loading is a better choice for the maintenance of systemic and pulmonary circulation during general and epidural anesthesia. Panminerva Medicine2014;56(1):35‐40. ">Yang Z 2014</a>; <a href="./references#CD005576-bbs2-0025" title="YousefshahiF , BashirzadehM , AbdollahiM , MojtahedzadehM , SalehiomranA , JalaliA , et al. Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft. Journal of the Tehran Heart Centre2013;8(1):21‐7. ">Yousefshahi F 2013</a>) (see <a href="./references#CD005576-sec-0135" title="">Characteristics of excluded studies</a>). We found no recently completed studies in registries of clinical trials including <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>; <a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com/</a>; and <a href="http://www.ifpma.org/clinicaltrials.html" target="_blank">www.ifpma.org/clinicaltrials.html</a>. </p> <div class="figure" id="CD005576-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD005576-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD005576-sec-0088"> <h4 class="title">Included studies</h4> <p>Eighteen studies with 1087 participants were included (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>) (see <a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). The included trials were performed in a wide variety of surgical situations: aortic surgery (four trials) (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>); lower limb surgery (three trials) (<a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>); transurethral prostate resection (three trials) (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>); coronary artery bypass grafting (three trials) (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>); hysterectomy (one trial) (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>); hernia repair (one trial) (<a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>); general surgery (one trial) (<a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>); pancreaticoduodenectomy (one trial) (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>); and neurological surgery (one trial) (<a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>). Anaesthetic techniques included: general anaesthesia (ten trials) (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>) and spinal anaesthesia (seven trials) (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>). </p> <p>Studies were performed in 11 countries, which include Brazil, China, Denmark, Finland, France, Germany, Indonesia, Japan, Lebanon, Niger, and USA. Four publications were written in languages other than English, including Japanese (two trials) (<a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>); French (one trial) (<a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>); Portuguese (one trial) (<a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>). The majority of included studies had small sample sizes, enrolling between 20 and 72 participants. The largest study enrolled 259 participants (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>). The interval between the first and last study was approximately 30 years (1983 to 2014). Only one of the studies was designed to determine differences in short‐term mortality (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), with the remaining studies focusing on fluid and haemodynamic measurement during the peri‐operative period. Follow‐up extended into the postoperative period in 10 trials (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>), with durations ranging from the stay in the recovery unit to 90 days postoperative, while the other trials confined their observations to the period of anaesthesia. Two studies reported results with standard error which we converted to standard deviation by multiplication with the square root of the number in the group (<a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>). </p> <p>Two authors of included studies whom we contacted for further information responded. Dr. Lavu kindly provided mean and standard deviation values that were not available in the publication (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), and Dr. Jarvela provided additional methodological details regarding random sequence generation and allocation concealment for two studies (<a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>). Dr. Shao was contacted regarding methodology but did not respond (<a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>). </p> </section> <section id="CD005576-sec-0089"> <h4 class="title">Excluded studies</h4> <p>Seven studies were found but ultimately excluded from analysis; two due to a lack of randomization (<a href="./references#CD005576-bbs2-0019" title="AulerJOC , PereiraMHC , Gomide‐AmaralRV , StolfNG , JateneAD , Rochae Silva M . Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms. Surgery1987;101:594‐601. ">Auler 1987</a>; <a href="./references#CD005576-bbs2-0023" title="ShaoYS , ZhangYT , PengKQ , QuanZY . Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma. World Journal of Gastroenterology2005;11(11):1577‐81. [MEDLINE: 15786530] ">Shao 2005</a>), two because there was no isotonic saline control group (<a href="./references#CD005576-bbs2-0021" title="LiJ , WangB , WangS , MuF . Effects of hypertonic saline ‐ hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures. International Journal of Clinical and Experimental Medicine2014;7(8):2266‐72. ">Li 2014</a>; <a href="./references#CD005576-bbs2-0022" title="LiQ , ChenH , HaoJJ , YinNN , XuM , ZhouJX . Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double‐blinded, randomised controlled trial. BMC Anesthesiology2015;15:138. NCT02037815 . Correlation of measured and calculated serum osmolality during mannitol or hypertonic saline infusion in patients after craniotomy: a study protocol and statistical analysis plan for a randomised controlled trial. clinicaltrials.gov/ct2/show/NCT02037815. ">Li 2015</a>), and three due to an absence of primary or secondary outcomes (<a href="./references#CD005576-bbs2-0020" title="AulerJOCJr , ZinWA , MartinsMA , YounesRN , NegriEM , HoelzC , et al. Respiratory system mechanics in patients treated with isotonic or hypertonic NaCl solutions. Circulatory Shock1992;36(4):243‐8. ">Auler 1992</a>; <a href="./references#CD005576-bbs2-0024" title="YangZ , ZongZ , KeC , WeiY , YuD , WangL , et al. Hetastarch with hypertonic saline loading is a better choice for the maintenance of systemic and pulmonary circulation during general and epidural anesthesia. Panminerva Medicine2014;56(1):35‐40. ">Yang Z 2014</a>; <a href="./references#CD005576-bbs2-0025" title="YousefshahiF , BashirzadehM , AbdollahiM , MojtahedzadehM , SalehiomranA , JalaliA , et al. Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft. Journal of the Tehran Heart Centre2013;8(1):21‐7. ">Yousefshahi F 2013</a>). Dr. Yousefshahi was contacted for further information but did not respond (<a href="./references#CD005576-bbs2-0025" title="YousefshahiF , BashirzadehM , AbdollahiM , MojtahedzadehM , SalehiomranA , JalaliA , et al. Effect of hypertonic saline infusion versus normal saline on serum NGAL and cystatin C levels in patients undergoing coronary artery bypass graft. Journal of the Tehran Heart Centre2013;8(1):21‐7. ">Yousefshahi F 2013</a>). </p> </section> </section> <section id="CD005576-sec-0090"> <h3 class="title">Risk of bias in included studies</h3> <p>The overall risk of bias in the included studies is undetermined due to a large number of studies (72%) not fully reporting methodology (<a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). The domains with the largest potential for bias are for performance and detection bias. For performance and detection bias, eight studies did not provide sufficient information to determine the potential for bias (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>) and five studies did not protect their studies from performance or detection bias (<a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>). Despite there being limited or unknown protection from performance bias it is unlikely that participants were informed of the fluid given to them for resuscitation. However, care givers and outcome assessors were either not blinded or insufficient information was given to determine the risk of bias, although this is unlikely to impact the majority of our measured outcomes, including mortality (<a href="./references#CD005576-fig-0006" title="">Analysis 1.1</a>), serious adverse events (<a href="./references#CD005576-fig-0007" title="">Analysis 1.2</a>), peak and final serum sodium (<a href="./references#CD005576-fig-0011" title="">Analysis 1.6</a>, <a href="./references#CD005576-fig-0012" title="">Analysis 1.7</a>), and maximum intraoperative serum osmolarity (<a href="./references#CD005576-fig-0013" title="">Analysis 1.8</a>), pulmonary artery wedge pressure (<a href="./references#CD005576-fig-0014" title="">Analysis 1.9</a>), and cardiac index (<a href="./references#CD005576-fig-0015" title="">Analysis 1.10</a>). Performance and detection bias could impact the results of fluid measurements, leaving the outcomes of fluid balance (<a href="./references#CD005576-fig-0008" title="">Analysis 1.3</a>), total volume of crystalloid administered (<a href="./references#CD005576-fig-0009" title="">Analysis 1.4</a>), and diuresis during study period (<a href="./references#CD005576-fig-0010" title="">Analysis 1.5</a>), at a greater risk of this source of bias and overall bias (<a href="#CD005576-fig-0002">Figure 2</a>; <a href="#CD005576-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD005576-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005576-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005576-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD005576-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD005576-sec-0091"> <h4 class="title">Allocation</h4> <p>Four trials described adequate random sequence generation (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), using a table of random numbers or computer‐generated random numbers. The remaining 14 studies alluded to randomization but did not describe the method used (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>). </p> <p>Adequate allocation concealment was reported in six trials, four in the publication (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>) and two through correspondence with the author (<a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>). </p> <p>From our assessment, four trials had a low risk of selection bias (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>) (<a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). </p> </section> <section id="CD005576-sec-0092"> <h4 class="title">Blinding</h4> <p>Five studies reported adequate concealment of treatment from participants, personnel, and outcome assessors (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>); we have rated them as having a low risk of performance and detection bias (<a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). </p> </section> <section id="CD005576-sec-0093"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed 16 trials at a low risk of attrition bias (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>;<a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>). Each of the 16 studies provided clear information about all participants including those with missing outcome data (<a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). </p> <p>Of the 1121 enrolled participants, 1087 completed the protocol. Four participants in the HS group failed to complete the study, one because of consent withdrawal (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>); one for an anaphylactic reaction to another medication (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>); one because of operative complication which met <i>a priori</i> exclusion criteria (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>); and one without a reason specified (<a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>). Seven participants in the IS group failed to complete the protocol, four because of operative complications which met a priori exclusion criteria (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), one because of an urgent return to the operating room for control of haemorrhage (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>); one because of a transfer to another hospital (<a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>) and one without a reason specified (<a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>). Twenty‐three participants failed to complete the protocol and were withdrawn from the studies without further information (<a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>). One participant was withdrawn from <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>, while the other study had 22 people removed from the analysis due to major protocol violation or incomplete data collection, although they were still included in the safety profile (<a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>). </p> </section> <section id="CD005576-sec-0094"> <h4 class="title">Selective reporting</h4> <p>Seventeen of the studies reported all of the clinically relevant outcomes that were appropriate for their trial design (<a href="./references#CD005576-bbs2-0001" title="BarakaA , TahaS , GhabachM , SibaiiA , NaderA , MattaM . Hypertonic saline prehydration in patients undergoing transurethral resection of the prostate under spinal anaesthesia. British Journal of Anaesthesia1994;72(2):227‐8. [MEDLINE: 7832822] ">Baraka 1994</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0016" title="VeroliP , BenhamouD . Comparison of hypertonic saline (5%), isotonic saline and Ringer's lactate solutions for fluid preloading before lumbar extradural anaesthesia. British Journal of Anaesthesia1992;69(5):461‐4. ">Veroli 1992</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>) (<a href="#CD005576-fig-0002">Figure 2</a>; <a href="#CD005576-fig-0003">Figure 3</a>). However, only one of the studies explicitly reported mortality (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>). The remaining studies imply there were no deaths through their other outcome data and we have assessed them to be at an unclear risk of reporting bias (<a href="#CD005576-fig-0003">Figure 3</a>). Additionally, the study by <a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a> reported a disproportionately low number of female participants and we have assessed this as an unclear risk of bias because it was not explained. </p> </section> <section id="CD005576-sec-0095"> <h4 class="title">Other potential sources of bias</h4> <p>Baseline parameters were reported in each study and appeared to be similar in both study groups in all trials. We found no evidence for other sources of bias in any of the studies (<a href="./references#CD005576-sec-0134" title="">Characteristics of included studies</a>). </p> </section> </section> <section id="CD005576-sec-0096"> <h3 class="title" id="CD005576-sec-0096">Effects of interventions</h3> <p>See: <a href="./full#CD005576-tbl-0001"><b>Summary of findings for the main comparison</b> Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</a> </p> <section id="CD005576-sec-0097"> <h4 class="title">Primary outcomes</h4> <section id="CD005576-sec-0098"> <h5 class="title">1. Mortality</h5> <p>One trial reported occurrences of deaths (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), four in the HS group and three in the IS group. From all of the studies there were 545 participants in the HS group and 542 in the IS group. Because only one study reported events an analysis to compare treatment groups could not be performed. Assessment of the HS group using the Clopper‐Person estimation shows that the upper bound for occurrences of events using a 95% CI is 0.019 (19/1000). Due to the paucity of events, neither a sensitivity nor subgroup analysis was feasible. We determine the quality of the evidence is very low (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD005576-sec-0099"> <h5 class="title">2. Serious adverse events</h5> <p>There were no reports of serious adverse events such as organ failure, myocardial infarction, cerebrovascular accident or central pontine myelinolysis reported in the trials. The outcome was not explicitly measured and we have extrapolated the data. There were 1087 participants, 542 in the IS group and 545 in the HS group. Although an analysis comparing the treatment groups cannot be performed, assessment of the HS group utilizing the Clopper‐Pearson estimation shows that the upper bound for occurrences of events using a 95% CI is 0.007 (7/1000). We have graded the quality of the evidence for this outcome as very low (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD005576-sec-0100"> <h5 class="title">Secondary outcomes</h5> </section> <section id="CD005576-sec-0101"> <h5 class="title">3. Fluid balance</h5> <p>Peri‐operative fluid balance was calculated in eight trials with 737 participants (51.1% HS, 48.9% IS) (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>;<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>). Overall, the fluid balance was positive in both groups (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>), the mean volume for the IS group being 4.4 L and 1.9 L lower for the HS group (MD ‐1.92, 95% CI ‐2.61 to ‐1.22; I² = 91%; P &lt; 0.00001; <a href="./references#CD005576-fig-0008" title="">Analysis 1.3</a>). We rate the quality of this evidence as low (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We conducted a sensitivity analysis using only studies deemed to have a low risk of bias (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>). The fluid balance was again found to be statistically significantly lower for the HS group (MD ‐1.47, 95% CI ‐2.84 to ‐0.09; participants = 279; P = 0.04; I² = 60%; <a href="./references#CD005576-fig-0016" title="">Analysis 2.1</a>). </p> <p>Subgroup analysis suggested no significant effect of the type of surgery (<a href="./references#CD005576-fig-0022" title="">Analysis 3.1</a>), dose of HS given (<a href="./references#CD005576-fig-0023" title="">Analysis 3.2</a>), or the total volume of fluid transfused (<a href="./references#CD005576-fig-0024" title="">Analysis 3.3</a>). There were too few studies to adequately investigate the high levels of heterogeneity. </p> </section> <section id="CD005576-sec-0102"> <h5 class="title">4. Total volume of crystalloid administered</h5> <p>The volume of intravenous fluid administered to participants was reported in 13 trials with 871 participants (51.3% HS, 48.7% IS) (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>). IS participants received a mean volume of 2.4 L (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). Participants in the HS group received 1.49 L, considerably less fluid intravenously than those in the IS group (MD ‐0.91, 95% CI ‐1.24 to ‐0.59; I² = 99%; P &lt; 0.00001; <a href="./references#CD005576-fig-0009" title="">Analysis 1.4</a>). We rate the quality of the evidence for this outcome as moderate (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We conducted a sensitivity analysis to include only studies deemed to be at low risk of bias (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>). We found that the amount of fluid used in the HS group was still statistically significantly less than in the IS group (MD ‐1.08, 95% CI ‐1.92 to ‐0.24; I² = 75%; P = 0.01; <a href="./references#CD005576-fig-0017" title="">Analysis 2.2</a>). </p> <p>A subgroup analysis according to type of surgery (<a href="./references#CD005576-fig-0025" title="">Analysis 3.4</a>) and the dose of HS (<a href="./references#CD005576-fig-0026" title="">Analysis 3.5</a>) did not reveal differences between the subgroups. The high degree of heterogeneity for this outcome was not explained by subgroup analysis according to type of surgery (<a href="./references#CD005576-fig-0025" title="">Analysis 3.4</a>) or the dose of HS (<a href="./references#CD005576-fig-0026" title="">Analysis 3.5</a>). Funnel plot analysis showed this outcome to cluster symmetrically (<a href="#CD005576-fig-0004">Figure 4</a>), except for three outliers from studies that used considerably more HS than other trials (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>). However, exclusion of these three trials from the analysis did not eliminate heterogeneity. </p> <div class="figure" id="CD005576-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 1.4 Total volume of crystalloid administered (L)." data-id="CD005576-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 1.4 Total volume of crystalloid administered (L). </p> </div> </div> </div> </section> <section id="CD005576-sec-0103"> <h5 class="title">5. Diuresis during study period</h5> <p>Urine output during the trial was reported in nine trials including 777 participants (51.1% HS, 48.9% IS) (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>). There was no difference in peri‐operative urine output (L) between the two groups (MD 0.11, 95% CI ‐0.09 to 0.31; I² = 69%; P = 0.28; <a href="./references#CD005576-fig-0010" title="">Analysis 1.5</a>). We rate the quality of the evidence to be low for risk of bias (downgraded one level because the majority of the studies have not confirmed blinding of outcome assessors, and bias could seriously impact this result) and imprecision (downgraded one level: the volume of crystalloid solution delivered has a large range between studies). </p> <p>A sensitivity analysis limited to studies with a low risk of bias (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>) did not change the findings of the outcome (MD 1.25, 95% CI ‐1.17 to 3.67; studies = 2; I² = 33%; <a href="./references#CD005576-fig-0018" title="">Analysis 2.3</a>). </p> <p>Stratification by type of surgery (<a href="./references#CD005576-fig-0027" title="">Analysis 3.6</a>), dose of HS (<a href="./references#CD005576-fig-0028" title="">Analysis 3.7</a>), or the total volume of crystalloid use in the IS group (<a href="./references#CD005576-fig-0029" title="">Analysis 3.8</a>) did not alter the outcome or the degree of heterogeneity. </p> </section> <section id="CD005576-sec-0104"> <h5 class="title">6. Peak serum sodium</h5> <p>The maximum serum sodium was measured in all but two trials (<a href="./references#CD005576-bbs2-0004" title="DurasnelP , CresciL , MadougouM , IdrissaA , CheriffI , FalandryL , et al. Practice of spinal anaesthesia in a developing country: usefulness of vascular preloading with a 7.5% hypertonic saline solution [Pratique de la rachianesthesie dans un pays en voie de development: interêt du remplissage vasculaire par un solute sale hypertonique a 7,5%]. Annales Françaises d'Anesthèsie et de Rèanimation1999;18(6):631‐5. [MEDLINE: 10464529] ">Durasnel 1999</a>; <a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>), and included 780 participants (50.6% HS, 49.4% IS) from 16 trials. Maximum serum sodium was higher in the HS group than the IS group, 147.4 versus 139.1 meq/L (MD 7.73, 95% CI 5.84 to 9.62; I² = 97%; P &lt; 0.00001; <a href="./references#CD005576-fig-0011" title="">Analysis 1.6</a>). The maximum average serum sodium ranged between 138.5 and 159 in HS groups compared to between 136 and 143 meq/L in the IS groups. We rate the quality of the evidence as moderate for this outcome (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Sensitivity analysis restricted to studies with a low risk of bias did not change the outcome or the heterogeneity of the studies (<a href="./references#CD005576-fig-0019" title="">Analysis 2.4</a>). </p> <p>Subgroup analysis by type of surgery (<a href="./references#CD005576-fig-0030" title="">Analysis 3.9</a>), the dose of crystalloid administered (<a href="./references#CD005576-fig-0031" title="">Analysis 3.10</a>), or by volume of HS (<a href="./references#CD005576-fig-0032" title="">Analysis 3.11</a>) did not alter the outcome or the heterogeneity between trials. Funnel plot analysis which showed peak serum sodium of each study clusters symmetrically around a positive MD. There is substantial overlap of MD from each study, regardless of the dose of HS given (<a href="#CD005576-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD005576-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 3.10 Peak serum sodium (meq/L) by dose of HS." data-id="CD005576-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 3.10 Peak serum sodium (meq/L) by dose of HS. </p> </div> </div> </div> </section> <section id="CD005576-sec-0105"> <h5 class="title">7. Final serum sodium</h5> <p>Twelve studies with 640 participants (51.4% HS, 48.6% IS) reported final serum sodium (<a href="./references#CD005576-bbs2-0002" title="BrueggerD , BauerA , RehmM , NiklasM , JacobM , IrlbeckM , et al. Effect of hypertonic saline dextran on acid‐base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine2005;33(3):556‐63. [MEDLINE: 15753747] ">Bruegger 2005</a>; <a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0017" title="WangBW , ChiouYH , ChenWB , PengTY , LeungHK . Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia. Acta Anaesthesiologica Sinica1997;35(2):85‐90. [MEDLINE: 9293648] ">Wang 1997</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>). By the end of the study period the serum sodium mean difference between the groups was considerably reduced from those reported at peak (MD 3.45, 95% CI 2.46 to 4.44; I² = 88%, P &lt; 0.00001; <a href="./references#CD005576-fig-0012" title="">Analysis 1.7</a>) and the range for final average serum sodium was within normal limits: 136 to 146 meq/L and 136 to 140 meq/L in the HS and IS groups respectively. We assess the quality of this evidence as moderate (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>A sensitivity analysis restricted to studies with a low risk of bias did not change the outcome or heterogeneity (<a href="./references#CD005576-fig-0020" title="">Analysis 2.5</a>). </p> <p>Neither the result nor heterogeneity were altered in subgroup analysis by surgery type (<a href="./references#CD005576-fig-0033" title="">Analysis 3.12</a>), dose of HS (<a href="./references#CD005576-fig-0034" title="">Analysis 3.13</a>) or volume of crystalloid (<a href="./references#CD005576-fig-0035" title="">Analysis 3.14</a>). </p> </section> <section id="CD005576-sec-0106"> <h5 class="title">8 ‐ 10. Duration of endotracheal intubation, intensive care stay and hospital stay</h5> <p>None of the trials reported the duration of mechanical ventilation and the length of stay in hospital. Only one trial (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>) reported the length of stay in intensive care, with mean stays (standard deviation) of 2.3 (0.2) versus 2.4 (0.6) days in the HS and IS groups respectively (P = 0.63). </p> </section> <section id="CD005576-sec-0107"> <h5 class="title">11. Other outcomes of interest</h5> <p>Ten trials with 369 participants (50.9% HS, 49.1% IS) (<a href="./references#CD005576-bbs2-0005" title="IshikawaG . The effect of hypertonic saline infusion on lumbar epidural anesthesia. Masui1996;45(2):205‐14. [MEDLINE: 8865710] ">Ishikawa 1996</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0008" title="KatoS , GotoF . Hypertonic saline for intraoperative fluid therapy in transurethral resection of the prostate. Journal of Anesthesia1996;10:170‐5. ">Kato 1996</a>; <a href="./references#CD005576-bbs2-0009" title="KimuraK , TakaoriM . The effects of hypertonic lactated Ringer's solution during transurethral surgery. Masui. The Japanese Journal of Anesthesiology1994;43(8):1141‐7. ">Kimura 1994</a>; <a href="./references#CD005576-bbs2-0010" title="Kølsen‐PetersenJA , NielsenJO , BendtzenK , TonnesenE . Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women. Acta Anaesthesiology Scandinavica2004;48(2):224‐33. [MEDLINE: 14995946] Kølsen‐PetersenJA , NielsenJO , TonnesenEM . Effect of hypertonic saline infusion on postoperative cellular immune function: a randomized controlled clinical trial. Anesthesiology2004;100(5):1108‐18. [MEDLINE: 15114207] Kølsen‐PetersenJA , RasmussenTB , KrogJ , HoklandM , TonnesenEK . Infusion of hypertonic saline (7.5%) does not change neutrophil oxidative burst or expression of endothelial adhesion molecules after abdominal hysterectomy. Journal of Trauma2006;61(5):1100‐6. [MEDLINE: 17099514] ">Kølsen‐Petersen 2004</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>; <a href="./references#CD005576-bbs2-0015" title="ShaoL , WangB , WangS , MuF , GuK . Comparison of 7.2% hypertonic saline ‐ 6% hydroxyethyl starch solution and 6%hydroxyethyl starch solution after the induction of anaesthesia in patients undergoing elective neurosurgical procedures. Clinics (Sao Paulo)2013;68(3):323‐8. ">Shao 2013</a>; <a href="./references#CD005576-bbs2-0018" title="YounesRN , BecharaMJ , LangerB , AunF , BiroliniD , KuznieckS , et al. Use of a hypertonic solution of 7.5% NaCl in preventing post‐declamping hypotension of the abdominal aorta [Emprego da solucao hipertonica de NaCl a 7,5% na prevencao do hipotensao pos‐desclampeamento da aorta abdominal]. AMB: Revista da Associação Médica Brasileira1988;34(5):150‐4. [MEDLINE: 3251309] ">Younes 1988</a>) reported maximum serum osmolarity (<a href="./references#CD005576-fig-0013" title="">Analysis 1.8</a>). We found that there was a statistically significant increase in serum osmolarity with HS, increased 5.3% from the median level of 289 mOsm/kg H20 in the IS group (MD 15.29 mOsm/kg H2O higher with HS, 95% CI 12.27 to 18.31; I² = 86%, P &lt; 0.00001). We assess the quality of the evidence to be moderate. We downgraded the study quality because of a high degree of heterogeneity that probably derives from the wide range of crystalloid fluid given across the studies. Future high‐quality studies are likely to change this result. </p> <p>Intraoperative pulmonary artery wedge pressure (<a href="./references#CD005576-fig-0014" title="">Analysis 1.9</a>) was reported in three studies with 150 participants (50.7% HS, 49.3% IS) (<a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>). There was no difference between the treatment groups (MD 0.16, 95% CI ‐1.69 to 2.02; I² = 0%; P = 0.86). </p> <p>Maximum intraoperative cardiac index was reported in six studies with 418 participants (51.7% HS, 48.3% IS) (<a href="./references#CD005576-bbs2-0003" title="CrossJS , GruberDP , BurchardKW , SinghAK , MoranJM , GannDS . Hypertonic saline fluid therapy following surgery: a prospective study. The Journal of Trauma1989;29(6):817‐25. [MEDLINE: 2661843] CrossJS , GruberDP , GannDS , SinghAK , MoranJM , BurchardKW . Hypertonic saline attenuates the hormonal response to injury. Annals of Surgery1989;209(6):684‐91. [MEDLINE: 2543337] ">Cross 1989</a>; <a href="./references#CD005576-bbs2-0006" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , HonkonenSE , JarvelaT , KoobiT , KaukinenS . The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anaesthesia. Anesthesia and Analgesia2000;91:1461‐5. JarvelaK , KoobiT , KauppinenP , KaukinenS . Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiologica Scandinavica2001;45(6):776‐81. [MEDLINE: 11421840] ">Jarvela 2000</a>; <a href="./references#CD005576-bbs2-0007" title="JarvalaK . Email correspondence (January 4, 2007)2007. JarvelaK , KaukinenS . Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology2001;18(2):100‐7. [MEDLINE: 11270018] JarvelaK , KaukinenS . Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia2002;16(1):43‐6. [MEDLINE: 11854877] JarvelaK , KoskinenM , KaukinenS , KoobiT . Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia2001;15(2):210‐5. [MEDLINE: 11312481] ">Jarvela 2001</a>; <a href="./references#CD005576-bbs2-0012" title="LeverveX , BoonC , HakimT , AnwarM , SiregarE , MustafaI . Half‐molar sodium‐lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Medicine2008;34:1796‐1803. ">Leverve 2008</a>; <a href="./references#CD005576-bbs2-0013" title="ShackfordSR , SiseMJ , FridlundPH , RowleyWR , PetersRM , VirgilioRW , et al. Hypertonic sodium lactate versus lactated ringer's solution for intravenous fluid therapy in operations on the abdominal aorta. Surgery1983;94(1):41‐51. ">Shackford 1983</a>; <a href="./references#CD005576-bbs2-0014" title="ShackfordSR , FortlageDA , PetersRM , Hollingsworth‐FridlundP , SiseMJ . Serum osmolar and electrolyte changes associated with large infusions of hypertonic sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction. Surgery, Gynecology and Obstetrics1987;164(2):127‐36. [MEDLINE: 3810427] ">Shackford 1987</a>). We found that the maximum intraoperative cardiac index was elevated 11.7% in the HS group over the median level of 2.9 L/min/m² in the IS group (MD 0.34, 95% CI 0.19 to 0.49; I² = 40%; P = 0.0001; <a href="./references#CD005576-fig-0015" title="">Analysis 1.10</a>). We rate the quality of these data to be high (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Although only one of the trials (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>) specifically reported adverse events, they have not met our criteria to be considered <i>serious</i> adverse events. Adverse events were reported over a 90‐day follow‐up period and the study found no difference between the HS and IS groups. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005576-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005576-sec-0108"></div> <section id="CD005576-sec-0109"> <h3 class="title" id="CD005576-sec-0109">Summary of main results</h3> <p>It was not possible to determine differences with respect to mortality or major morbidity between the treatment arms of this meta‐analysis. A preliminary survey carried out before designing the meta‐analysis suggested that trials of peri‐operative HS were usually designed to measure fluid volumes, haemodynamics and biochemistry rather than measure important clinical outcomes. Despite this, we chose mortality as the primary outcome for this review and we collected serious adverse event data because of their clinical importance. </p> <p>Peri‐operative diuresis was similar in the HS and IS participants, suggesting that adequate intravascular volumes were maintained throughout surgery despite the fact that HS participants received significantly less intravenous fluid than IS participants (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). All of the participant groups completed surgery with a positive fluid balance (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). In some trials, the positive fluid balance was almost 10 L by the end of surgery. Pulmonary oedema was not recorded in the trials but it is reasonable to be concerned that excess fluid of this magnitude would result in pulmonary oedema in a population at risk of this complication. Use of HS significantly reduced the positive fluid balance experienced by all participants undergoing surgery. HS increased serum sodium and osmolarity (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). The doses of HS varied considerably between trials, but even in those who received very high doses of HS no adverse events related to hypernatraemia were encountered. Serum sodium returned to normal limits by the end of the study. </p> </section> <section id="CD005576-sec-0110"> <h3 class="title" id="CD005576-sec-0110">Overall completeness and applicability of evidence</h3> <p>Meta‐analysis of the outcomes measured by the trials provides a reasonably complete picture of the immediate impact of HS on peri‐operative fluid management. HS significantly reduces the positive fluid balance experienced by people undergoing surgery while maintaining a stable haemodynamic state. This observation was independent of the type of surgery or whether peri‐operative fluid protocol was restricted or unrestricted by volume. HS conserved fluid at lower doses as much as at higher doses. However the trials were not designed to look at the impact of the interventions on mortality or longer‐term morbidity. </p> <p>To date, we have only found one trial where mortality and adverse events were explicitly measured over a period that extended beyond the original hospital stay (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>). Mortality at 90 days did not differ between treatment groups of participants undergoing pancreaticoduodenectomy, but there is no evidence to suggest that this result would remain true at different centres or for different procedures. Until there are more, high‐power studies examining mortality in different surgical procedures at multiple centres, we cannot say with certainty that there is no effect of HS on mortality. This same study also measured postoperative complications (non‐serious adverse events). Although the result was not statistically significant, there were over 10% more postoperative complications in the IS group. Future trials will be necessary to test this finding. </p> <p>This review showed that people receiving HS had a transient increase in serum sodium (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). Hypernatraemia has the potential to harm but this was not seen in the included studies. In hyponatraemic people, the risk of central pontine myelinolysis is thought to be related to underlying conditions more than the rate of electrolyte repletion, but increases in serum sodium of more than 10 meq/L per day should be avoided if possible (<a href="./references#CD005576-bbs2-0034" title="KumarS , FowlerM , Gonzalez‐ToledoE , JaffeSL . Central pontine myelinolysis, an update. Neurological Research2006;28(3):360‐6. [MEDLINE: 16687066] ">Kumar 2006</a>). It is not known if people with normal serum sodium are at a similar risk of hyperosmotically induced demyelination. No episodes of central pontine myelinolysis were reported in these studies where the participants had normal serum sodium levels at baseline, and we did not find any case reports in the literature of central pontine myelinolysis in people who received HS. </p> <p>Is there a potential therapeutic window for HS in people undergoing surgery, where peri‐operative weight gain can be minimized without a risk of significant hypernatraemia? Hypernatraemia is transient after administration of HS. However, it would seem prudent to avoid large increases in serum sodium. This is possible, with these studies suggesting that up to 10 ml/kg of 3% HS will reduce the positive fluid balance peri‐operatively by up to 1.5 L in the average adult without increasing serum sodium inappropriately. There is insufficient evidence to determine if such a reduction in peri‐operative fluid excess would improve clinically relevant outcomes but it provides the basis for an RCT. </p> <p>The evidence is strong for a reduction in the volume of peri‐operative fluid required to maintain homeostasis with HS. There is no direct evidence that this results in better survival or quality of life. The principal barrier to meta‐analysis of some outcomes is a high degree of heterogeneity between the trials. Heterogeneity appears to be due to differences in the magnitude of the effect observed rather than differences in the effect itself. Subgroup analysis identified sources of heterogeneity in some instances. For example, there was considerable heterogeneity in peri‐operative diuresis even though there was no significant difference in diuresis between the test group, HS, and the control. </p> <p>Overall there is a strong need for well‐controlled, high‐quality studies with adequate design to measure both short‐ and long‐term variables. The results of this systematic review and future studies could prove to be very important to patient care, particularly when low volumes of resuscitating fluid are needed. At this time the results show promise for HS as a safe choice for resuscitation during surgery where reduced volumes would be beneficial, but more evidence is needed. </p> </section> <section id="CD005576-sec-0111"> <h3 class="title" id="CD005576-sec-0111">Quality of the evidence</h3> <p>The quality of evidence across these trials ranged from high to very low. The majority of trials included in this study cover relatively few participants. The trials were conducted in several eras when other peri‐operative practices may have changed. There was also a large variation in the dose of HS given between studies which may have resulted in the high heterogeneity between them. Furthermore, many of the studies did not specify the methods of allocation concealment or randomization, which again probably reflects the era in which many of the studies were reported. </p> <p>For determining mortality, the trials lacked sufficient size, duration and reporting to adequately assess important differences. Furthermore, only one study (<a href="./references#CD005576-bbs2-0011" title="LavuH , SellNM , CarterTI , WinterJM , MaguireDP , GratchDM , et al. The HYSLAR Trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Annals of Surgery2014;290(3):445‐55. Lavu , H . Personal communication. Personal communicationJanuary 2015. ">Lavu 2014</a>) explicitly reported the outcome, and we have extrapolated the data on the basis that other outcomes were reported by each study for all included participants. We have assessed the quality of evidence for mortality to be very low, and future studies are likely to change the result reported here (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We rate the quality of the evidence for fluid balance and diuresis to be low (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). There is a systemic lack of blinding of personnel across these studies, leaving these outcomes prone to bias. High‐quality study results are likely to change this outcome. </p> <p>The reporting of peak and final serum sodium is of moderate quality (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). The level of blood sodium during surgery is a common hospital measurement that is unlikely to be biased. The difference in the number of samples collected by the different studies impacts the quality of this outcome. Future studies are likely to change this result. </p> <p>We have rated the quality of the evidence for the maximum intraoperative cardiac index as high (<a href="./full#CD005576-tbl-0001">summary of findings Table for the main comparison</a>). The measurement during an operation is a common hospital procedure that is unlikely to be biased. The studies that report this outcome are well controlled, and the values reported are consistent across the studies. Future studies are unlikely to change this result. </p> </section> <section id="CD005576-sec-0112"> <h3 class="title" id="CD005576-sec-0112">Potential biases in the review process</h3> <p>Having searched the largest medical research data bases, without limit by language of publication, it is highly likely that we have found all published data that met our inclusion criteria. </p> <p>The review authors tried to reduce the impact of personal bias in the presentation and analysis of the results. When assessing the degree that individual bias components would impact study results, we have undoubtedly relied on our own experiences. We have assumed, in cases where the information was not available, that the reports were conducted by compassionate physicians and dedicated researchers who have performed their work honestly and to the best of their abilities. Because of this, we have left our analysis open to being impacted by fraudulent reports. </p> </section> <section id="CD005576-sec-0113"> <h3 class="title" id="CD005576-sec-0113">Agreements and disagreements with other studies or reviews</h3> <p>This is the first systematic review of HS compared to IS for peri‐operative fluid management. This update confirms the findings of the first version (<a href="./references#CD005576-bbs2-0044" title="McAlisterV , BurnsKEA , ZnajdaT , ChurchB . Hypertonic saline for peri‐operative fluid management. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD006233] ">McAlister 2006</a>). The findings are consistent with reviews of HS given for other indications such as fluid management in people with burns (<a href="./references#CD005576-bbs2-0028" title="BunnF , RobertsI , TaskerR , AkpaE . Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD002045.pub2; MEDLINE: 15266460] ">Bunn 2004</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005576-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD005576-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005576-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD005576-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 1.4 Total volume of crystalloid administered (L)." data-id="CD005576-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 1.4 Total volume of crystalloid administered (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 3.10 Peak serum sodium (meq/L) by dose of HS." data-id="CD005576-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, outcome: 3.10 Peak serum sodium (meq/L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Mortality during the study period." data-id="CD005576-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Mortality during the study period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Serious adverse events during the study period." data-id="CD005576-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Serious adverse events during the study period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) measured at the end of the recovery period." data-id="CD005576-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) measured at the end of the recovery period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L)." data-id="CD005576-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Diuresis during study period (L)." data-id="CD005576-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Diuresis during study period (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Peak serum sodium (meq/L)." data-id="CD005576-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Peak serum sodium (meq/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Final serum sodium (meq/L)." data-id="CD005576-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Final serum sodium (meq/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Maximum intraoperative serum osmolarity (mOsm/kg H2O)." data-id="CD005576-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Maximum intraoperative serum osmolarity (mOsm/kg H2O). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Maximum intraoperative pulmonary artery wedge pressure (mm Hg)." data-id="CD005576-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Maximum intraoperative pulmonary artery wedge pressure (mm Hg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Maximum intraoperative cardiac index (L/min/M2)." data-id="CD005576-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Maximum intraoperative cardiac index (L/min/M<sup>2</sup>). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) measured during the study period: studies at low risk of bias." data-id="CD005576-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) measured during the study period: studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Total volume of crystalloid administered (L): studies at low risk of bias." data-id="CD005576-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Total volume of crystalloid administered (L): studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Diuresis during study period (L): studies at low risk of bias." data-id="CD005576-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Diuresis during study period (L): studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Peak serum sodium (meq/L): studies at low risk of bias." data-id="CD005576-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Peak serum sodium (meq/L): studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Final serum sodium (meq/L): studies at low risk of bias." data-id="CD005576-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Final serum sodium (meq/L): studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Maximum intraoperative serum osmolarity (mOsm/kg H2O): studies at low risk of bias." data-id="CD005576-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Maximum intraoperative serum osmolarity (mOsm/kg H2O): studies at low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) by type of surgery." data-id="CD005576-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 1 Fluid balance (L) by type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Fluid balance (L) by dose of HS." data-id="CD005576-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 2 Fluid balance (L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) by volume given to control group." data-id="CD005576-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 3 Fluid balance (L) by volume given to control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L) by type of surgery." data-id="CD005576-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 4 Total volume of crystalloid administered (L) by type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Total volume of crystalloid administered (L) by dose of HS." data-id="CD005576-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 5 Total volume of crystalloid administered (L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Diuresis during study period (L) by type of surgery." data-id="CD005576-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 6 Diuresis during study period (L) by type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Diuresis during study period (L) by dose of HS." data-id="CD005576-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 7 Diuresis during study period (L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Diuresis during study period (L) by volume given to control group." data-id="CD005576-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 8 Diuresis during study period (L) by volume given to control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Peak serum sodium (meq/L) by type of surgery." data-id="CD005576-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 9 Peak serum sodium (meq/L) by type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-10.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Peak serum sodium (meq/L) by dose of HS." data-id="CD005576-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 10 Peak serum sodium (meq/L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 11 Peak serum sodium (meq/L) by volume given to control group." data-id="CD005576-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 11 Peak serum sodium (meq/L) by volume given to control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 12 Final serum sodium (meq/L) by type of surgery." data-id="CD005576-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 12 Final serum sodium (meq/L) by type of surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 13 Final serum sodium (meq/L) by dose of HS." data-id="CD005576-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 13 Final serum sodium (meq/L) by dose of HS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005576-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/urn:x-wiley:14651858:media:CD005576:CD005576-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_t/tCD005576-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 14 Final serum sodium (meq/L) by volume given to control group." data-id="CD005576-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation, Outcome 14 Final serum sodium (meq/L) by volume given to control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/media/CDSR/CD005576/image_n/nCD005576-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005576-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> any people undergoing surgery with fluid resuscitation<br/> <b>Settings:</b> people undergoing non‐emergency surgery that requires fluid resuscitation in a hospital operating room in;Brazil, China,Denmark, Finland, France, Germany, Indonesia, Japan, Lebanon, Niger, USA.<br/> <b>Intervention:</b> hypertonic salt solution<br/> <b>Comparison:</b> isotonic salt solution </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> isotonic salt solution for peri‐operativeresuscitation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Hypertonic salt</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality</p> <p>Follow‐up: range 1 to 90 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1087<br/> (18 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Any recorded death during the study period. The risk of bias impacting this outcome is considered to be low. Only one study had incidents of mortality </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> <p>Follow‐up: range 1 to 90 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1087</p> <p>(18 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse outcomes are collected as defined by each trial or if any of the following occurred: any organ failure, including renal, pulmonary, cardiac, or cerebral </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluid balance (L)</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fluid balance (L) was 4.375</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean fluid balance (L) in the intervention group was 1.92 lower (2.61 lower to 1.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>737<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The change in participant fluid volume at the end of fluid administration. A neutral fluid balance would be optimal </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total volume of crystalloid administered (L)</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of crystalloid administered (L) was 2.43</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean total volume of crystalloid administered (L) in the intervention group was 0.91 lower (1.24 lower to 0.59 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>871<br/> (13 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The total volume of fluid delivered intravenously over the study period. There are no defined minimum or maximum values for fluid delivery during surgery. Less resuscitating fluid is preferred </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peak serum sodium</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean peak serum sodium (meq/L) was 139.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean peak serum sodium (meq/L) in the intervention group was 7.73 higher (5.84 higher to 9.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>780<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is a common practice in operative procedures. Measured as the peak amount of sodium in the blood, given in milliequivelants per litre, over the study period. The normal acceptable range is 136 to 146 meq/L </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Final serum sodium</p> <p>Follow‐up: range 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final serum sodium (meq/L) was 138.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean final serum sodium (meq/L) in the intervention group was 3.45 higher (2.46 higher to 4.44 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is common practice in operative procedures. Measured as the final amount of sodium in the blood, given in milliequivelants per litre, at the end of the study. The normal acceptable range is 136 to 146 meq/L </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Maximum intraoperative cardiac index</p> <p>Follow‐up: 1 to 3 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maximum intraoperative cardiac index (L/min/M²) was 2.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean maximum intraoperative cardiac index (L/min/m²) in the intervention group was 0.34 higher (0.19 higher to 0.49 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The measurement of this variable is common practice in operative procedures. Measured by the volume of blood passing through one square meter each minute (L/min/M²). The normal range is 2.5 ‐ 4.0 L/min/M² </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded (2 levels) for indirectness: The majority of studies have an insufficient follow‐up period to adequately measure the outcome.<br/> <sup>2</sup>Downgraded (1 level) for publication bias: Only one study contributes explicit evidence for the outcome.<br/> <sup>3</sup>Downgraded (1 level) for risk of bias: The majority of the studies have not confirmed blinding of outcome assessors; bias could seriously impact this result.<br/> <sup>4</sup>Downgraded (1 level) for imprecision: The volume of crystalloid solution delivered between studies has a large range.<br/> <sup>5</sup>Downgraded (1 level) for imprecision: The duration of sample collection varies widely from study to study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hypertonic salt compared to isotonic salt solution for peri‐operative resuscitation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/full#CD005576-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005576-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality during the study period <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1087</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events during the study period <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1087</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fluid balance (L) measured at the end of the recovery period <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.92 [‐2.61, ‐1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total volume of crystalloid administered (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>871</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐1.24, ‐0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Diuresis during study period (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.09, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Peak serum sodium (meq/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>780</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.73 [5.84, 9.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Final serum sodium (meq/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.45 [2.46, 4.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maximum intraoperative serum osmolarity (mOsm/kg H2O) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>369</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.29 [12.27, 18.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Maximum intraoperative pulmonary artery wedge pressure (mm Hg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐1.69, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maximum intraoperative cardiac index (L/min/M<sup>2</sup>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.19, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005576-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Fluid balance (L) measured during the study period: studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.47 [‐2.84, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total volume of crystalloid administered (L): studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.08 [‐1.92, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Diuresis during study period (L): studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [‐1.17, 3.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Peak serum sodium (meq/L): studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.03 [3.96, 8.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Final serum sodium (meq/L): studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.48 [0.33, 4.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maximum intraoperative serum osmolarity (mOsm/kg H2O): studies at low risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.81 [12.86, 18.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005576-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Fluid balance (L) by type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.92 [‐2.61, ‐1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Aortic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.84 [‐6.45, ‐1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Neurosurgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐1.59, ‐0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Hepatobiliary surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐2.20, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Coronary artery bypass surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐1.92, ‐0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Fluid balance (L) by dose of HS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.91 [‐2.61, ‐1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 &lt; 7.1 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐1.59, ‐0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 7.1 ‐ 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐1.22, ‐0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 &gt; 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.08 [‐5.23, ‐0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fluid balance (L) by volume given to control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.91 [‐2.61, ‐1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 &lt; 2000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 2000 ‐ 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.31 [‐1.92, ‐0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 &gt; 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.87 [‐5.29, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Total volume of crystalloid administered (L) by type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>871</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐1.24, ‐0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.14 [‐1.71, ‐0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Non‐cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐1.05, ‐0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total volume of crystalloid administered (L) by dose of HS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>871</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐1.24, ‐0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 &lt; 7.1 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.77 [‐1.19, ‐0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 7.1 ‐ 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.25, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 &gt; 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.50 [‐4.99, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Diuresis during study period (L) by type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.10, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>438</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.22, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Non‐cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.30, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Diuresis during study period (L) by dose of HS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.10, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 &lt; 7.1 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.54, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 7.1 ‐ 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.12, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 &gt; 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [‐0.50, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Diuresis during study period (L) by volume given to control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>777</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.11, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 &lt; 2000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.16, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 2000 ‐ 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [‐0.19, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 &gt; 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.48, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Peak serum sodium (meq/L) by type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>780</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.73 [5.84, 9.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.61 [6.91, 14.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Transurethral resection of the prostate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.01 [1.86, 6.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Other surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.52 [3.64, 9.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Peak serum sodium (meq/L) by dose of HS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>780</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.73 [5.84, 9.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 &lt; 7.1 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.31 [2.00, 8.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 7.1 ‐ 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.93 [5.16, 12.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 &gt; 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.75 [5.50, 13.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Peak serum sodium (meq/L) by volume given to control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.10 [6.66, 11.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 &lt; 2000 mL/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.94 [3.53, 6.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 2000 ‐ 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.05 [4.54, 13.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 &gt; 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.93 [11.44, 16.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Final serum sodium (meq/L) by type of surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.45 [2.46, 4.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Cardiovascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.91 [2.55, 5.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Transurethral resection of prostate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.45, 3.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Other surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.77, 5.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Final serum sodium (meq/L) by dose of HS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.45 [2.46, 4.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 &lt; 7.1 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.69 [1.70, 5.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 7.1 ‐ 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.63 [1.17, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 &gt; 10 mL 3% HS/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.56 [3.16, 7.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Final serum sodium (meq/L) by volume given to control group <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.73 [2.29, 5.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 &lt; 2000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [‐0.74, 5.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 2000 ‐ 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.14 [1.02, 5.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 &gt; 5000 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.70 [3.98, 7.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis ‐ hypertonic salt versus isotonic salt solution for peri‐operative resuscitation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005576.pub3/references#CD005576-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005576.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005576-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005576-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005576-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005576-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD005576-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD005576-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD005576-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD005576-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005576-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005576\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005576\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005576\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005576\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005576\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=4nUWI3Cc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005576.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005576.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005576.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005576.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005576.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718063348"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005576.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718063352"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005576.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc72dceb3f49c',t:'MTc0MDcxODA2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 